VANCOUVER, BRITISH COLUMBIA--(Marketwire - January 15, 2010) - Meridian Co., Ltd. (OTCBB: MRDAF) is very pleased to announce the return of Ms. Anna Brazier as Director of Corporate Finances after her one year leave due to medical issues. "I look forward to an exciting year for Meridian Co.," says Brazier, "and I would like to thank all the shareholders for their patience, support and understanding".
Brazier has been instrumental in the success of Meridian Co. since 2003. "We are pleased to have Brazier focus her energies on MRDAF as she has been a very important member of our management and development team, and is a true asset to our organization", states Director & CFO, MR. In B. Park.
Both parties have come to terms with an agreement that will be beneficial to both the shareholders and the growth of the company.
More About: Meridian
Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 5 patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide
This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.